Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers

Kathleen F. Kerr, Allison Meisner, Heather Thiessen Philbrook, Steven G. Coca, Chirag Parikh

Research output: Contribution to journalArticle

Abstract

The field of nephrology is actively involved in developing biomarkers and improving models for predicting patients’ risks of AKI and CKD and their outcomes. However, some important aspects of evaluating biomarkers and risk models are not widely appreciated, and statistical methods are still evolving. This review describes some of the most important statistical concepts for this area of research and identifies common pitfalls. Particular attention is paid to metrics proposed within the last 5 years for quantifying the incremental predictive value of a new biomarker.

Original languageEnglish (US)
Pages (from-to)1488-1496
Number of pages9
JournalClinical Journal of the American Society of Nephrology
Volume9
Issue number8
DOIs
StatePublished - Jan 1 2014

Fingerprint

Biomarkers
Kidney
Wounds and Injuries
Nephrology
Research

ASJC Scopus subject areas

  • Epidemiology
  • Critical Care and Intensive Care Medicine
  • Nephrology
  • Transplantation

Cite this

Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers. / Kerr, Kathleen F.; Meisner, Allison; Thiessen Philbrook, Heather; Coca, Steven G.; Parikh, Chirag.

In: Clinical Journal of the American Society of Nephrology, Vol. 9, No. 8, 01.01.2014, p. 1488-1496.

Research output: Contribution to journalArticle

@article{98cc6d4d56574524bc78525d376de4ac,
title = "Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers",
abstract = "The field of nephrology is actively involved in developing biomarkers and improving models for predicting patients’ risks of AKI and CKD and their outcomes. However, some important aspects of evaluating biomarkers and risk models are not widely appreciated, and statistical methods are still evolving. This review describes some of the most important statistical concepts for this area of research and identifies common pitfalls. Particular attention is paid to metrics proposed within the last 5 years for quantifying the incremental predictive value of a new biomarker.",
author = "Kerr, {Kathleen F.} and Allison Meisner and {Thiessen Philbrook}, Heather and Coca, {Steven G.} and Chirag Parikh",
year = "2014",
month = "1",
day = "1",
doi = "10.2215/CJN.10351013",
language = "English (US)",
volume = "9",
pages = "1488--1496",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "8",

}

TY - JOUR

T1 - Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers

AU - Kerr, Kathleen F.

AU - Meisner, Allison

AU - Thiessen Philbrook, Heather

AU - Coca, Steven G.

AU - Parikh, Chirag

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The field of nephrology is actively involved in developing biomarkers and improving models for predicting patients’ risks of AKI and CKD and their outcomes. However, some important aspects of evaluating biomarkers and risk models are not widely appreciated, and statistical methods are still evolving. This review describes some of the most important statistical concepts for this area of research and identifies common pitfalls. Particular attention is paid to metrics proposed within the last 5 years for quantifying the incremental predictive value of a new biomarker.

AB - The field of nephrology is actively involved in developing biomarkers and improving models for predicting patients’ risks of AKI and CKD and their outcomes. However, some important aspects of evaluating biomarkers and risk models are not widely appreciated, and statistical methods are still evolving. This review describes some of the most important statistical concepts for this area of research and identifies common pitfalls. Particular attention is paid to metrics proposed within the last 5 years for quantifying the incremental predictive value of a new biomarker.

UR - http://www.scopus.com/inward/record.url?scp=84919794934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919794934&partnerID=8YFLogxK

U2 - 10.2215/CJN.10351013

DO - 10.2215/CJN.10351013

M3 - Article

C2 - 24855282

AN - SCOPUS:84919794934

VL - 9

SP - 1488

EP - 1496

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 8

ER -